Skip to main content

Table 1 Patient characteristics

From: Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study

 

HAND

HIVOI

HIVM

HIVasy

OIND

OND

p-value

n

14

25

5

21

18

22

 

age (mean and STD)

45.2 (11.9)

41.5 (10.4)

33.8 (12)

35.9 (11.2)

51.6 (19.2)

42.6 (12.4)

0.007

female gender (%)

3 (21.4%)

5 (20.0%)

2 (40.0%)

0 (0.0%)

9 (50.0%)

15 (65.2%)

< 0.001

CSF cells/μl (mean and STD)

5.9 (7.5)

12.9 (15.1)

65.9 (94.9)

2.3 (2.3)

2313 (3051)

2 (2)

< 0.001

IgG-index (mean and STD)

0.97 (0.39)

0.88 (0.27)

0.60 (0.14)

0.63 (0.15)

0.82 (0.48)

0.48 (0.07)

< 0.001

Qalb (mean and STD)

9.3 (3.9)

10.8 (6.6)

12.9 (8.8)

6.8 (5.7)

47.3 (48.8)

5.6 (2.3)

< 0.001

MOG IgG serum positivity (%)

7 (50.0%)

10 (40.0%)

1 (20.0%)

1 (4.8%)

6 (33.3%)

1 (4.5%)

0.003